-
MMP-2 Liposomes for Sequential PD-1/IDO Blockade
2026-08-15
The reference study develops an MMP-2-responsive, dual-targeting liposome that delivers the PD-1 pathway-blocking peptide AUNP-12 before exposing a tumor-cell-targeting module carrying the IDO inhibitor NLG919. Its sequential design reactivates antitumor T-cell responses while remodeling the immunosuppressive breast cancer microenvironment, offering a useful framework for studying coordinated combination immunotherapy.
-
Carrier-Platin and the ROS Storm in Cancer Cells
2026-08-14
Liu and colleagues developed carrier-platin, a poly(amino acids)-based platinum nanotherapeutic that confines ultrasmall platinum nanoparticles and rapidly amplifies intracellular reactive oxygen species. The study links this ROS burst to cancer-cell death that is independent of DNA damage and classified as neither apoptosis nor ferroptosis, offering a mechanistically distinct strategy for multidrug-resistant tumors.
-
KR-12 Antimicrobial Peptides: Design and Applications
2026-08-14
The 2024 review of KR-12 positions this compact LL-37-derived peptide as a versatile scaffold for antimicrobial and immunomodulatory design. It explains how sequence engineering, chemical stabilization, nanoformulation, and biomaterial immobilization can improve activity, biofilm control, delivery, and translational potential while highlighting the limitations of heterogeneous preclinical evidence.
-
Recombinant Human Oncostatin M: Assay Guide
2026-08-13
Recombinant Human Oncostatin M (rh-Oncostatin M) is a tag-free, lyophilized cytokine for controlled proliferation and cytokine-release assays. Product-reported potency, purity, endotoxin, reconstitution, and storage parameters support assay planning, while current peritoneal-fibrosis evidence provides biological context rather than direct validation of OSM activity.
-
Nigericin BA1112: Reliable Cell Assay Workflows
2026-08-13
Nigericin (SKU BA1112) is a potassium/hydrogen ion carrier for investigating intracellular pH, mitochondrial membrane ion transport, viability, and cytotoxicity responses. This scenario-based guide explains formulation, controls, storage, interpretation, and vendor-selection considerations for more reproducible cell assays.
-
Tetracycline Hydrochloride: Mechanism-Aware Assays
2026-08-12
Tetracycline Hydrochloride is a bacteriostatic antibiotic whose ribosome-level activity can sharpen antimicrobial and skin microbiome experiments. This article develops a mechanism-aware assay framework and contrasts translation inhibition with rapid ROS-driven cancer-cell death.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-12
Build a more sensitive Western blot workflow for scarce signaling proteins, including Lin28B and PBK, without relying on highly concentrated antibodies. This guide connects horseradish peroxidase chemiluminescence with TNBC target-validation experiments, practical assay design, and troubleshooting for nitrocellulose and PVDF membranes.
-
Fluconazole Workflows for Candida Research
2026-08-11
Build more informative fungal assays with Fluconazole as a mechanistic ergosterol-pathway control, not merely a growth-inhibition reagent. This guide connects antifungal susceptibility testing, resistance profiling, and Candida albicans infection model design with the emerging METTL9–PRA1 mucosal defense pathway.
-
Palonosetron Hydrochloride: Assay Design Guide
2026-08-11
Palonosetron hydrochloride is more than a long-acting 5-HT3 receptor antagonist. This assay-focused guide connects receptor pharmacology with OCT2 and MATE1 transport studies, helping researchers select endpoints, concentration ranges, and translational controls.
-
Tolazoline for α2-Adrenergic Receptor Studies
2026-08-10
Tolazoline is a flexible pharmacological probe for separating α2-adrenergic receptor signaling from ATP-sensitive potassium channel effects in airway and pancreatic islet models. This guide translates the compound’s evidence base into executable workflows, concentration-selection logic, and troubleshooting practices for reproducible bench research.
-
LINC01550 Suppresses CRC via Wnt/β-Catenin
2026-08-09
This study identifies LINC01550 as a potentially tumor-suppressive long noncoding RNA in colorectal cancer and connects its loss to advanced disease, poorer survival, and activation of Wnt/β-catenin signaling. By combining TCGA-based analysis with functional assays in HCT-116 and HT-29 cells, the authors provide a mechanistic framework for evaluating LINC01550 as a prognostic biomarker and experimental therapeutic target.
-
Antibiotic-Resistant E. coli in Hanoi Rodents
2026-08-08
This study surveyed fecal Escherichia coli from 144 urban rodents in Hanoi and identified multidrug-resistant, ESBL-producing, and colistin-resistant isolates. Its main contribution is to connect urban rodent carriage with a broader public-health surveillance framework that combines resistance phenotypes, resistance determinants, and diarrheagenic E. coli markers.
-
Cell Cycle Assay Kit: From DNA to Mechanism
2026-08-07
Discover how the Cell Cycle Assay Kit (K2263) converts DNA-content measurements into mechanistic insight for epigenetic cancer studies. This guide connects PI flow cytometry, sub-G1 interpretation, and panobinostat research while defining the assay’s strengths and limitations.
-
FerroOrange Fe²⁺ Fluorescent Probe: Live Cell Iron Detection
2026-08-07
FerroOrange enables precise, real-time quantification of intracellular Fe²⁺ dynamics in live cells, revolutionizing workflows in iron metabolism and ferroptosis research. Its high specificity, compatibility with advanced imaging, and proven performance in mechanistic studies empower reliable detection where legacy probes fall short.
-
CCK-8 in Drug-Resistant AML: Assay Precision for Translation
2026-08-06
Explore how the Cell Counting Kit-8 (CCK-8) advances cell viability and cytotoxicity analysis in drug-resistant acute myeloid leukemia (AML) models. This article uniquely bridges robust assay selection with emerging translational strategies in cancer research.